Evidence map›Paper›PMID 40078389›Full record

ReviewFrontiers in medicine2025

A review of sarcoidosis etiology, diagnosis and treatment.

Yahya Mostafa Waly, Abu-Baker Khalid Sharafeldin, Muhammad Umair Akhtar, Zaid Chilmeran, Salim Fredericks

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. BMC pulmonary medicine · 2026
    Observational
  4. Observational
  5. Review
  6. Review
  7. Scoping out sarcoidosis: the evolving role of bronchoscopy.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yahya Mostafa WalySchool of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.
Abu-Baker Khalid SharafeldinSchool of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.
Muhammad Umair AkhtarSchool of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.
Zaid ChilmeranSchool of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.
Salim FredericksSchool of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in various organs, leading to inflammation and potential organ dysfunction. Symptoms often start with general signs like fatigue, fever, and weight loss, but vary depending on the affected organ. Diagnosis is challenging due to its diverse clinical presentation and lack of a definitive test, while treatment is complicated by the disease's variable course, requiring a personalized approach. This review explores the role of genetic and environmental factors in sarcoidosis etiology, examines current challenges in diagnosis and treatment, and discusses how understanding etiology informs patient management and future treatment strategies.

Indexed as

diagnosisetiologygranulomaspersonalized treatmentsarcoidosis

Identifiers

PMID40078389
PMCPMC11897256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.